A Clinical Study to Evaluate the Effect of Guduchighan Vati in the Management of Vatarakta w.s.r to Hyperuricemia

College Principal0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patient of either sex in the age group between 20-70 years.
•2.Patient having serum uric acid level more then 7mg/dl(male) and 6mg/dl(female) with or without any associated features of joint inflammation.
•3.Willing to participate and able to provide signed informed consent.

•1.Patient not willing for the trial.
•2.Patient below age of 20 years and above 70 years of age.
•3.Patient suffering from any other form of Arthritis like R.A, O.A, Tubercular Arthritis, Rheumatoid Arthritis etc.
•4.Patient suffering from chronic renal, respiratory, cardiac and hepatic disorders.
•5.Patient having malignant disorders.
•6. Patient who has completed participation in any other clinical trial during the past 3 months.
•7.Any condition which the investigator thinks may compromise with the safety of the object.

发起方

College Principal